Low levels of high-density lipoprotein cholesterol increase the risk of incident kidney disease and its progression

Kidney International

Volumn 89, Issue 4, 2016, Pages 886-896

  Bowe, Benjamin ^a   Xie, Yan ^a   Xian, Hong ^a,b   Balasubramanian, Sumitra ^a   Al Aly, Ziyad ^a,c  

^a VA St Louis Healthcare System   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cholesterol; chronic kidney disease; high density lipoprotein; incidence of kidney disease; kidney disease progression

Indexed keywords

CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ADVERSE OUTCOME; ARTICLE; BODY MASS; CHEMICAL PARAMETERS; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMOGRAPHY; DISEASE COURSE; DYSLIPIDEMIA; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL; UNITED STATES; VETERAN; AGED; BLOOD; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; CHOLESTEROL, HDL; DISEASE PROGRESSION; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 84964691547     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1016/j.kint.2015.12.034     Document Type: Article

References (48)

1. A. Cases, and E. Coll Dyslipidemia and the progression of renal disease in chronic renal failure patients Kidney Int Suppl Dec(99) 2005 S87 S93
2. N.D. Vaziri, M. Navab, and A.M. Fogelman HDL metabolism and activity in chronic kidney disease Nat Rev Nephrol 6 2010 287 296
3. A. Ganda, M. Magnusson, L. Yvan-Charvet, and et al. Mild renal dysfunction and metabolites tied to low HDL cholesterol are associated with monocytosis and atherosclerosis Circulation 127 2013 988 996
4. S. Homma, N. Murayama, I. Yoshida, and et al. Marked atherosclerosis in a patient with familiar lecithin: cholesterol acyltransferase deficiency associated with end-stage renal disease and diabetes mellitus Am J Nephrol 21 2001 415 419
5. E. Gjone Familial lecithin:cholesterol acyltransferase deficiency - a new metabolic disease with renal involvement Adv Nephrol Necker Hosp 10 1981 167 185
6. P. Muntner, J. Coresh, J.C. Smith, and et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study Kidney Int 58 2000 293 301
7. J. Morton, S. Zoungas, Q. Li, and et al. Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study Diabetes Care 35 2012 2201 2206
8. E.S. Schaeffner, T. Kurth, G.C. Curhan, and et al. Cholesterol and the risk of renal dysfunction in apparently healthy men J Am Soc Nephrol 14 2003 2084 2091
9. M. Manttari, E. Tiula, T. Alikoski, and et al. Effects of hypertension and dyslipidemia on the decline in renal function Hypertension 26 1995 670 675
10. N.D. Vaziri Causes of dysregulation of lipid metabolism in chronic renal failure Semin Dial 22 2009 644 651
11. F. Wang, J. Zheng, P. Ye, and et al. Association of high-density lipoprotein cholesterol with the estimated glomerular filtration rate in a community-based population PloS One 8 2013 e79738
12. A. Baragetti, G.D. Norata, C. Sarcina, and et al. High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease J Int Med 274 2013 252 262
13. M. Rahman, W. Yang, S. Akkina, and et al. Relation of serum lipids and lipoproteins with progression of CKD: The CRIC study Clin J Am Soc Nephrol 9 2014 1190 1198
14. B.F. Voight, G.M. Peloso, M. Orho-Melander, and et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study Lancet 380 2012 572 580
15. R.S. Kalil, J.H. Wang, I.H. de Boer, and et al. Effect of extended-release niacin on cardiovascular events and kidney function in chronic kidney disease: a post hoc analysis of the AIM-HIGH trial Kidney Int 87 2015 1250 1257
16. P. Fioretto, P.M. Dodson, D. Ziegler, and et al. Residual microvascular risk in diabetes: unmet needs and future directions Nat Rev Endocrinol 6 2010 19 25
17. K. Tsuruya, H. Yoshida, M. Nagata, and et al. Association of the triglycerides to high-density lipoprotein cholesterol ratio with the risk of chronic kidney disease: analysis in a large Japanese population Atherosclerosis 233 2014 260 267
18. C. Giannini, N. Santoro, S. Caprio, and et al. The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds Diabetes Care 34 2011 1869 1874
19. F.M. Sacks, M.P. Hermans, P. Fioretto, and et al. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries Circulation 129 2014 999 1008
20. D. Gasevic, J. Frohlich, G.B. Mancini, and et al. The association between triglyceride to high-density-lipoprotein cholesterol ratio and insulin resistance in a multiethnic primary prevention cohort Metabolism 61 2012 583 589
21. S.A. Mostafa, M.J. Davies, D.H. Morris, and et al. The association of the triglyceride-to-HDL cholesterol ratio with insulin resistance in White European and South Asian men and women PloS One 7 2012 e50931
22. K. Tsuruya, H. Yoshida, M. Nagata, and et al. Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of CKD: a longitudinal study in a large Japanese population Am J Kidney Dis 66 2015 972 983
23. Z. Al-Aly, S. Balasubramanian, J.R. McDonald, and et al. Greater variability in kidney function is associated with an increased risk of death Kidney Int 82 2012 1208 1214
24. Z. Al-Aly Prediction of renal end points in chronic kidney disease Kidney Int 83 2013 189 191
25. Z. Al-Aly, A. Zeringue, J. Fu, and et al. Rate of kidney function decline associates with mortality J Am Soc Nephrol 21 2010 1961 1969
26. Y. Xie, B. Bowe, H. Xian, and et al. Rate of kidney function decline and risk of hospitalizations in stage 3A CKD Clin J Am Soc Nephrol 10 2015 1946 1955
27. C.Y. Huang, F.Y. Lin, C.M. Shih, and et al. Moderate to high concentrations of high-density lipoprotein from healthy subjects paradoxically impair human endothelial progenitor cells and related angiogenesis by activating Rho-associated kinase pathways Arterioscler Thromb Vasc Biol 32 2012 2405 2417
28. J.P. Corsetti, D. Ryan, D.L. Rainwater, and et al. Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels Arterioscler Thromb Vasc Biol 30 2010 1657 1664
29. J.P. Corsetti, W. Zareba, A.J. Moss, and et al. Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation Atherosclerosis 187 2006 191 197
30. J.P. Corsetti, R.T. Gansevoort, C.E. Sparks, and et al. Inflammation reduces HDL protection against primary cardiac risk Eur J Clin Invest 40 2010 483 489
31. E.M. deGoma, N.J. Leeper, and P.A. Heidenreich Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol J Am Coll Cardiol 51 2008 49 55
32. W.A. van der Steeg, I. Holme, S.M. Boekholdt, and et al. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies J Am Coll Cardiol 51 2008 634 642
33. H. Moradi, E. Streja, M.L. Kashyap, and et al. Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients Nephrol Dial Transplant 29 2014 1554 1562
34. Z. Al-Aly Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy Transl Res 151 2008 233 239
35. Z. Al-Aly Phosphate, oxidative stress, and nuclear factor-kappaB activation in vascular calcification Kidney Int 79 2011 1044 1047
36. I.H. de Boer, and J.D. Brunzell HDL in CKD: how good is the "good cholesterol?" J Am Soc Nephrol 25 2014 871 874
37. J. Muller-Deile, and R. Schmitt HDL in CKD: not protective any longer? Kidney Int 85 2014 712
38. P.A. Murphy, D.C. Cowper, G. Seppala, and et al. Veterans Health Administration inpatient and outpatient care data: an overview Eff Clin Pract 5 2002 E4
39. E.Z. Oddone, and S. Eisen Veterans Affairs Research and Development: using science to improve health care for veterans N C Med J 69 2008 35 37
40. VIReC Research User Guide: VHA Medical SAS Outpatient Datasets FY2006. U.S. Department of Veterans Affairs. VA Information Resource Center: Hines I, September 2007.
41. VIReC Research User Guide: VHA Medical SAS Inpatient Datasets FY2006. U.S. Department of Veterans Affairs. VA Information Resource Center: Hines I, September 2007.
42. VIReC Research User Guide: Veterans Health Administration Decision Support System Clinical National Data Extracts H, IL, U.S. Department of Veterans Affairs. VA Information Resource Center, September 2009.
43. J. Coresh, T.C. Turin, K. Matsushita, and et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality JAMA 311 2014 2518 2531
44. A.M. O'Hare, D. Bertenthal, K.E. Covinsky, and et al. Mortality risk stratification in chronic kidney disease: one size for all ages? J Am Soc Nephrol 17 2006 846 853
45. Y. Xie Renal function trajectories in patients with prior improved eGFR slopes and risk of death PloS One 2015
46. D.G. Kleinbaum, and M. Klein Survival Analysis 2005 Springer New York, NY
47. H. Heinzl, and A. Kaider Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions Comput Methods Programs Biomed 54 1997 201 208
48. T.C. Turin, J. Coresh, M. Tonelli, and et al. Change in the estimated glomerular filtration rate over time and risk of all-cause mortality Kidney Int 83 2013 684 691